HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202,693 | -32.5% | 134,234 | +11.7% | 0.00% | – |
| Q4 2022 | $300,508 | -48.5% | 120,203 | -13.0% | 0.00% | -100.0% |
| Q3 2022 | $583,000 | +77.7% | 138,217 | +17.2% | 0.00% | – |
| Q2 2022 | $328,000 | -57.7% | 117,886 | -13.2% | 0.00% | -100.0% |
| Q1 2022 | $776,000 | -40.7% | 135,833 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $1,308,000 | +12.9% | 143,262 | +32.1% | 0.00% | 0.0% |
| Q3 2021 | $1,159,000 | -9.5% | 108,416 | +31.3% | 0.00% | 0.0% |
| Q2 2021 | $1,281,000 | +21.2% | 82,587 | +26.5% | 0.00% | 0.0% |
| Q1 2021 | $1,057,000 | -65.4% | 65,271 | -54.8% | 0.00% | 0.0% |
| Q4 2020 | $3,057,000 | +28.5% | 144,369 | -10.1% | 0.00% | 0.0% |
| Q3 2020 | $2,379,000 | +1.8% | 160,563 | +1.0% | 0.00% | -50.0% |
| Q2 2020 | $2,338,000 | +68.1% | 158,935 | +34.1% | 0.00% | +100.0% |
| Q1 2020 | $1,391,000 | -68.1% | 118,495 | -36.2% | 0.00% | -66.7% |
| Q4 2019 | $4,364,000 | +222.8% | 185,676 | +154.2% | 0.00% | +200.0% |
| Q3 2019 | $1,352,000 | +52.8% | 73,042 | +53.4% | 0.00% | 0.0% |
| Q2 2019 | $885,000 | -34.4% | 47,609 | -13.8% | 0.00% | 0.0% |
| Q1 2019 | $1,350,000 | -44.4% | 55,235 | -41.1% | 0.00% | -66.7% |
| Q4 2018 | $2,430,000 | +35.0% | 93,705 | +64.7% | 0.00% | +50.0% |
| Q3 2018 | $1,800,000 | -16.9% | 56,903 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $2,166,000 | +27.4% | 55,782 | -9.4% | 0.00% | 0.0% |
| Q1 2018 | $1,700,000 | +93.0% | 61,593 | +26.4% | 0.00% | +100.0% |
| Q4 2017 | $881,000 | -11.2% | 48,724 | -20.7% | 0.00% | 0.0% |
| Q3 2017 | $992,000 | -28.2% | 61,423 | -38.4% | 0.00% | 0.0% |
| Q2 2017 | $1,382,000 | -36.0% | 99,744 | -30.8% | 0.00% | -50.0% |
| Q1 2017 | $2,161,000 | +392.3% | 144,061 | +329.8% | 0.00% | – |
| Q4 2016 | $439,000 | -45.8% | 33,522 | -28.7% | 0.00% | -100.0% |
| Q3 2016 | $810,000 | -20.0% | 47,040 | -16.0% | 0.00% | 0.0% |
| Q2 2016 | $1,012,000 | -3.2% | 56,002 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $1,045,000 | +51.2% | 55,020 | +112.7% | 0.00% | 0.0% |
| Q4 2015 | $691,000 | +161.7% | 25,869 | +138.8% | 0.00% | – |
| Q3 2015 | $264,000 | -67.6% | 10,834 | -58.6% | 0.00% | -100.0% |
| Q2 2015 | $815,000 | +252.8% | 26,185 | +57.7% | 0.00% | – |
| Q1 2014 | $231,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |